Caution urged on ketamine

It’s too early to recommend ketamine as a treatment for depression despite promising results from preliminary trials, says an Australian clinical and research psychiatrist.

Concerned that strong public demand may prompt off-label use of the drug, she says efficacy and safety has yet to be properly tested.

Writing in the MJA, Professor Colleen Loo from the University of NSW and the Black Dog